AvKare recalled 2,003 cartons of Chlorpromazine Hydrochloride Tablets on August 25, 2025. The recall stems from the presence of a foreign substance in the medication. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Presence of a foreign substance.
Consumers and healthcare providers should stop using this product immediately. Contact AvKARE or your healthcare provider for guidance. Notification method: E-Mail
The recalled product is Chlorpromazine Hydrochloride Tablets, USP, 100 mg, packaged in 50-tablet cartons. Lot numbers include 47089 and 47604, with expiration dates of December 31, 2025, and March 31, 2026. The medication was distributed nationwide in the USA.
The recall is classified as Class II due to the potential health risks associated with the presence of a foreign substance in the tablets. This could pose a serious health risk to consumers.
There are no reported incidents or injuries associated with this recall at this time. Consumers are advised to discontinue use as a precaution.
Consumers should stop using the recalled Chlorpromazine Hydrochloride Tablets immediately. Contact AvKARE or consult a healthcare provider for further guidance on the recall.
For more information, consumers can email AvKARE or visit their website. The FDA recall notice can also be found at the provided link.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.